| Primary |
| Hiv Infection |
53.6% |
| Hiv Test Positive |
30.4% |
| Asymptomatic Hiv Infection |
2.4% |
| Antiretroviral Therapy |
1.8% |
| Prophylaxis |
1.8% |
| Drug Use For Unknown Indication |
1.5% |
| Acquired Immunodeficiency Syndrome |
1.3% |
| Ill-defined Disorder |
1.3% |
| Infection Prophylaxis |
1.3% |
| Prophylaxis Against Hiv Infection |
0.8% |
| Systemic Antiviral Treatment |
0.8% |
| Product Used For Unknown Indication |
0.7% |
| Blood Cholesterol Increased |
0.6% |
| Hypertension |
0.6% |
| Lentivirus Test Positive |
0.5% |
| Heart Rate Irregular |
0.2% |
| Complex Partial Seizures |
0.1% |
| Fungal Infection |
0.1% |
| Insomnia |
0.1% |
| Mental Status Changes |
0.1% |
|
| Drug Exposure During Pregnancy |
24.4% |
| Abortion Spontaneous |
7.3% |
| Polydactyly |
6.7% |
| Premature Baby |
6.7% |
| Pregnancy |
6.1% |
| Stillbirth |
5.5% |
| Vomiting |
5.5% |
| Intra-uterine Death |
4.9% |
| Trisomy 21 |
4.3% |
| Ebstein's Anomaly |
3.7% |
| Hepatic Enzyme Increased |
3.0% |
| Urinary Tract Malformation |
3.0% |
| Visual Disturbance |
3.0% |
| Facial Dysmorphism |
2.4% |
| No Adverse Event |
2.4% |
| Trisomy 18 |
2.4% |
| Viral Load Increased |
2.4% |
| Vision Blurred |
2.4% |
| Acute Myeloid Leukaemia |
1.8% |
| Ascites |
1.8% |
|
| Secondary |
| Hiv Infection |
69.3% |
| Drug Exposure During Pregnancy |
5.8% |
| Acquired Immunodeficiency Syndrome |
5.5% |
| Antiretroviral Therapy |
4.4% |
| Drug Use For Unknown Indication |
3.8% |
| Antiviral Prophylaxis |
1.9% |
| Antiviral Treatment |
1.8% |
| Product Used For Unknown Indication |
1.2% |
| Hepatitis C |
1.0% |
| Prophylaxis |
1.0% |
| Pathogen Resistance |
0.9% |
| Diabetes Mellitus |
0.8% |
| Oral Candidiasis |
0.6% |
| Human Immunodeficiency Virus Transmission |
0.4% |
| Nerve Root Lesion |
0.4% |
| Antifungal Prophylaxis |
0.4% |
| Antibiotic Prophylaxis |
0.3% |
| Hiv Test Positive |
0.3% |
| Prophylaxis Against Hiv Infection |
0.3% |
| Constipation |
0.2% |
|
| Drug Exposure During Pregnancy |
21.0% |
| Pregnancy |
9.0% |
| Stillbirth |
8.6% |
| Trisomy 21 |
5.2% |
| White Blood Cell Count Decreased |
4.7% |
| Cryptorchism |
4.3% |
| Neutropenia |
4.3% |
| Pancreatic Mass |
4.3% |
| Polydactyly |
4.3% |
| Urine Abnormality |
4.3% |
| Progressive External Ophthalmoplegia |
3.9% |
| Varices Oesophageal |
3.9% |
| Maternal Drugs Affecting Foetus |
3.4% |
| Platelet Count Decreased |
3.4% |
| Premature Baby |
3.0% |
| Pyrexia |
3.0% |
| Lumbar Vertebral Fracture |
2.6% |
| Ventricular Septal Defect |
2.6% |
| Abortion Spontaneous |
2.1% |
| Atrial Septal Defect |
2.1% |
|
| Concomitant |
| Hiv Infection |
67.5% |
| Acquired Immunodeficiency Syndrome |
6.5% |
| Drug Exposure During Pregnancy |
5.6% |
| Factor Viii Deficiency |
2.8% |
| Haemorrhoids |
2.4% |
| Drug Use For Unknown Indication |
1.7% |
| Hepatitis C |
1.7% |
| Lower Gastrointestinal Haemorrhage |
1.5% |
| Antiviral Treatment |
1.1% |
| Antiviral Prophylaxis |
1.1% |
| Exposure During Pregnancy |
1.1% |
| Mycobacterium Avium Complex Infection |
1.1% |
| Systemic Antiviral Treatment |
1.1% |
| Depression |
0.9% |
| Product Used For Unknown Indication |
0.8% |
| Prophylaxis |
0.8% |
| Convulsion Prophylaxis |
0.7% |
| Weight Decreased |
0.6% |
| Asymptomatic Hiv Infection |
0.6% |
| Liver Disorder |
0.6% |
|
| Stillbirth |
9.9% |
| Drug Exposure During Pregnancy |
8.6% |
| Pregnancy |
8.6% |
| Ventricular Septal Defect |
8.0% |
| Premature Baby |
6.8% |
| Pyrexia |
4.9% |
| White Blood Cell Count Decreased |
4.9% |
| Liver Disorder |
4.3% |
| Osteonecrosis |
4.3% |
| Polydactyly |
4.3% |
| Trisomy 21 |
4.3% |
| Ultrasound Antenatal Screen Abnormal |
4.3% |
| Neutropenia |
3.7% |
| Renal Failure Acute |
3.7% |
| Weight Decreased |
3.7% |
| Abortion Spontaneous |
3.1% |
| Tremor |
3.1% |
| Tricuspid Valve Incompetence |
3.1% |
| Trisomy 15 |
3.1% |
| Urinary Tract Infection |
3.1% |
|
